ym 09151-2 has been researched along with guanylyl imidodiphosphate in 3 studies
Studies (ym 09151-2) | Trials (ym 09151-2) | Recent Studies (post-2010) (ym 09151-2) | Studies (guanylyl imidodiphosphate) | Trials (guanylyl imidodiphosphate) | Recent Studies (post-2010) (guanylyl imidodiphosphate) |
---|---|---|---|---|---|
249 | 6 | 13 | 2,356 | 1 | 18 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchman, O; Grigoriadis, DE; Niznik, HB; Pri-Bar, I; Seeman, P | 1 |
Maeno, H | 1 |
Meltzer, HY; Overholser, JC; Stockmeier, CA; Sumiyoshi, T; Thompson, PA | 1 |
3 other study(ies) available for ym 09151-2 and guanylyl imidodiphosphate
Article | Year |
---|---|
Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
Topics: Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Corpus Striatum; Dogs; Guanylyl Imidodiphosphate; Ketanserin; Kinetics; Piperidines; Receptors, Dopamine; Sodium; Spiperone; Substrate Specificity; Tetrahydronaphthalenes | 1985 |
Dopamine receptors in canine caudate nucleus.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Affinity Labels; Animals; Antipsychotic Agents; Benzamides; Catecholamines; Caudate Nucleus; Corpus Striatum; Cyclic AMP; Dogs; Dopamine; Fluorides; Guanylyl Imidodiphosphate; Humans; Kinetics; Motor Activity; Nucleotides; Phosphorylation; Photochemistry; Rats; Receptors, Dopamine; Stereotyped Behavior; Substantia Nigra | 1982 |
Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Caudate Nucleus; Depressive Disorder; Dopamine Antagonists; Female; GTP-Binding Proteins; Guanine Nucleotides; Guanylyl Imidodiphosphate; Humans; In Vitro Techniques; Kinetics; Male; Middle Aged; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Schizophrenia | 1995 |